An Update on the Controversies in Anemia Management in Chronic Kidney Disease: Lessons Learned and Lost
Background. Erythropoietin deficiency and anemia occur in Chronic Kidney Disease (CKD) and may be treated with Erythropoietin Stimulating Agents (ESAs). The optimal hemoglobin, in non-End Stage Renal Disease CKD, is controversial. Methods. We review three recent randomized trials in anemia in CKD: C...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2011-01-01
|
| Series: | Anemia |
| Online Access: | http://dx.doi.org/10.1155/2011/623673 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|